177 related articles for article (PubMed ID: 17158931)
1. Mouse mutants reveal that putative protein interaction sites in the p53 proline-rich domain are dispensable for tumor suppression.
Toledo F; Lee CJ; Krummel KA; Rodewald LW; Liu CW; Wahl GM
Mol Cell Biol; 2007 Feb; 27(4):1425-32. PubMed ID: 17158931
[TBL] [Abstract][Full Text] [Related]
2. Activation of p53 following ionizing radiation, but not other stressors, is dependent on the proline-rich domain (PRD).
Campbell HG; Mehta R; Neumann AA; Rubio C; Baird M; Slatter TL; Braithwaite AW
Oncogene; 2013 Feb; 32(7):827-36. PubMed ID: 22484427
[TBL] [Abstract][Full Text] [Related]
3. A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network.
Toledo F; Krummel KA; Lee CJ; Liu CW; Rodewald LW; Tang M; Wahl GM
Cancer Cell; 2006 Apr; 9(4):273-85. PubMed ID: 16616333
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of cellular target genes by p53 devoid of the PXXP motifs with impaired apoptotic activity.
Zhu J; Jiang J; Zhou W; Zhu K; Chen X
Oncogene; 1999 Mar; 18(12):2149-55. PubMed ID: 10321740
[TBL] [Abstract][Full Text] [Related]
5. Biological significance of a small highly conserved region in the N terminus of the p53 tumour suppressor protein.
Liu WL; Midgley C; Stephen C; Saville M; Lane DP
J Mol Biol; 2001 Nov; 313(4):711-31. PubMed ID: 11697899
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel p53 functional domain that is necessary for efficient growth suppression.
Walker KK; Levine AJ
Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15335-40. PubMed ID: 8986812
[TBL] [Abstract][Full Text] [Related]
7. Mutations in proline 82 of p53 impair its activation by Pin1 and Chk2 in response to DNA damage.
Berger M; Stahl N; Del Sal G; Haupt Y
Mol Cell Biol; 2005 Jul; 25(13):5380-8. PubMed ID: 15964795
[TBL] [Abstract][Full Text] [Related]
8. The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response.
Zheng H; You H; Zhou XZ; Murray SA; Uchida T; Wulf G; Gu L; Tang X; Lu KP; Xiao ZX
Nature; 2002 Oct; 419(6909):849-53. PubMed ID: 12397361
[TBL] [Abstract][Full Text] [Related]
9. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
[TBL] [Abstract][Full Text] [Related]
10. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults.
Zacchi P; Gostissa M; Uchida T; Salvagno C; Avolio F; Volinia S; Ronai Z; Blandino G; Schneider C; Del Sal G
Nature; 2002 Oct; 419(6909):853-7. PubMed ID: 12397362
[TBL] [Abstract][Full Text] [Related]
11. The proline-rich region of mouse p53 influences transactivation and apoptosis but is largely dispensable for these functions.
Edwards SJ; Hananeia L; Eccles MR; Zhang YF; Braithwaite AW
Oncogene; 2003 Jul; 22(29):4517-23. PubMed ID: 12881708
[TBL] [Abstract][Full Text] [Related]
12. The proline rich domain of p53 is dispensable for MGMT-dependent DNA repair and cell survival following alkylation damage.
Baran K; Yang M; Dillon CP; Samson LL; Green DR
Cell Death Differ; 2017 Nov; 24(11):1925-1936. PubMed ID: 28753207
[TBL] [Abstract][Full Text] [Related]
13. p53 Protein is activated by Pin1: and also by Cu-SOD prion-like enzyme.
Wiseman A
Med Hypotheses; 2005; 65(1):32-4. PubMed ID: 15893113
[TBL] [Abstract][Full Text] [Related]
14. The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells.
Baptiste N; Friedlander P; Chen X; Prives C
Oncogene; 2002 Jan; 21(1):9-21. PubMed ID: 11791172
[TBL] [Abstract][Full Text] [Related]
15. The proline repeat domain of p53 binds directly to the transcriptional coactivator p300 and allosterically controls DNA-dependent acetylation of p53.
Dornan D; Shimizu H; Burch L; Smith AJ; Hupp TR
Mol Cell Biol; 2003 Dec; 23(23):8846-61. PubMed ID: 14612423
[TBL] [Abstract][Full Text] [Related]
16. The 7-amino-acid site in the proline-rich region of the N-terminal domain of p53 is involved in the interaction with FAK and is critical for p53 functioning.
Golubovskaya VM; Finch R; Zheng M; Kurenova EV; Cance WG
Biochem J; 2008 Apr; 411(1):151-60. PubMed ID: 18215142
[TBL] [Abstract][Full Text] [Related]
17. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
[TBL] [Abstract][Full Text] [Related]
18. p53 binds the nuclear matrix in normal cells: binding involves the proline-rich domain of p53 and increases following genotoxic stress.
Jiang M; Axe T; Holgate R; Rubbi CP; Okorokov AL; Mee T; Milner J
Oncogene; 2001 Sep; 20(39):5449-58. PubMed ID: 11571642
[TBL] [Abstract][Full Text] [Related]
19. Integrating mutation data and structural analysis of the TP53 tumor-suppressor protein.
Martin AC; Facchiano AM; Cuff AL; Hernandez-Boussard T; Olivier M; Hainaut P; Thornton JM
Hum Mutat; 2002 Feb; 19(2):149-64. PubMed ID: 11793474
[TBL] [Abstract][Full Text] [Related]
20. Mdm4 loss in mice expressing a p53 hypomorph alters tumor spectrum without improving survival.
Fang M; Simeonova I; Bardot B; Lejour V; Jaber S; Bouarich-Bourimi R; Morin A; Toledo F
Oncogene; 2014 Mar; 33(10):1336-9. PubMed ID: 23474762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
